Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
2.100
+0.320 (17.98%)
Apr 9, 2026, 12:50 PM EDT - Market open
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $257.56 million as of April 9, 2026. Its market cap has increased by 104.57% in one year.
Market Cap
257.56M
Enterprise Value
170.73M
1-Year Change
104.57%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $257.56M, a decrease of -29.14%. That is a compound annual growth rate of -4.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 197.47M | -3.77% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Minerva Neurosciences | 234.55M |
| Voyager Therapeutics | 233.63M |
| Fennec Pharmaceuticals | 223.74M |
| MediWound | 221.96M |
| Enlivex | 221.50M |
| OmniAb | 220.79M |
| MacroGenics | 219.27M |
| Compugen | 216.53M |